P ulmonary hypertension (PH) is a progressive condition comprising a group of uncommon disorders of the pulmonary circulation, characterized by sustained elevations of pulmonary artery pressure, right-sided heart failure, progressive dyspnea, fatigue, and profound functional limitations. The demographic profile of the adult PH population includes men and women of all ages and racial and ethnic groups. During 1995 to 2002, 9 million patients were hospitalized with PH, and 117 000 deaths were attributed to PH. 1 In the past, the prognosis of PH has been 2.8 years with 1-, 3-, and 5-year survival rates of 68%, 48%, and 34%, respectively, in untreated patients. 1 The Food and Drug Administration has approved 9 pharmacologic therapies for the treatment of PH. 2 Although pharmacologic therapies for PH improve pulmonary hemodynamics and exercise capacity and have significantly improved the long-term prognosis of PH, these pharmacologic therapies may or may not have a positive impact on health-related quality of life (HRQOL). Health-related quality of life is the balance between that which is desired in life and that which is achieved or achievable and includes the physiological, psychological, and situational factors in an individual's life. 3 At present, little is known about the determinants of HRQOL in the adult PH population. Factors that may contribute to a decrease in HRQOL include dyspnea, fatigue, functional limitations, adverse effects of therapy, social isolation, depression, anxiety, and stress. An improved understanding of these contributing factors will be essential as HRQOL becomes an important outcome in research on pharmacologic therapies for PH. Because of chronicity of disease, poor prognosis, and contributing factors, HRQOL is an important clinical end point to evaluate in the adult PH population.
LITERATURE REVIEW
Pulmonary hypertension has become an increasingly important cause of morbidity and mortality in the modern world. In addition to the pathophysiological changes and functional problems, patients with PH must strive to cope with psychosocial factors such as depression, anxiety, stress, and situational factors including social support and financial issues. Physiological, psychological, and situational complexities associated with PH may cause the patient to experience a reduction in HRQOL. The aforementioned complexities include, but are not limited to, annual treatment cost of $18 000 to $240 000, isolation and impaired social relationships, complex medical regimen and care, disability and medical assistance, and life-threatening issues. 4 The Minnesota Living With Heart Failure questionnaire has been administered to patients with PH to evaluate HRQOL. The words ''heart failure'' were replaced with ''pulmonary hypertension'' in the questionnaire. The mean physical and emotional scores of the Minnesota Living With Heart FailureYPH were elevated and statistically significant (P G .001), indicating patients with PH experience considerable problems with HRQOL. Higher scores on the questionnaire indicate worse HRQOL. Symptoms associated with a reduction in HRQOL included abdominal bloating, fatigue, weakness, leg swelling, and light headedness. Hemodynamic parameters did not correlate with HRQOL except for right atrial pressure (r = 0.29, P G .05), and even this correlation was not strong according to Spearman correlation. 5 Many patients with PH continue to report a diminished HRQOL despite increased pharmacologic therapy for PH. The Registry to Evaluate Early and Long-term (REVEAL) PH Disease Management was a multicenter observational cohort study that discovered 25% of patients with PH experience depression. 6 Depression can cause a decrease in HRQOL. 2 Health-related quality of life has been evaluated in individuals with PH in previous studies. 4Y7 Factors such as dyspnea, functional limitations, adverse effects of therapy, social isolation, anxiety, and depression were measured. 4Y7 Findings from a study in which 3 HRQOL questionnaires were administered include subjects reporting a moderate to severe impairment in physical mobility, emotional reaction, pain, energy, sleep, and social isolation in all 3 HRQOL questionnaires. 7 Standard gamble techniques were used to measure preferences for current health. Initially, patients were are asked to think about their current health state with PH and then to consider whether they would prefer to remain in that health state for the next 10 years or take a chance with a new treatment. The patients were told the new treatment had the ability to return them to perfect health immediately with no adverse effects but also had the ability to cause instant death. Standard gamble utilities were 0.71, which indicates PH subjects were willing to accept a 29% risk of death in order to be cured of this devastating disease. 8 Studies have evaluated the prevalence of depression, anxiety disorders, and other mental disorders in patients with PH. 8, 9 Results from questionnaires suggest PH participants had depressive disorder (15.6%) or panic disorder (10.4%). 8 A high prevalence of panic attacks (25.6%) was present among patients with PH. The prevalence of panic attacks was 4 to 6 times greater than the national rates for major depressive disorder (3.8%) and panic disorder (1.8%). 9 The physiological, psychosocial, and situational factors increase the PH patients' need for holistic care, including attention to the patient's environment and support systems. The middle-range Theory of Unpleasant Symptoms was used as the framework for this research study. The theory provides an inclusion framework for the 2 common PH symptoms of dyspnea and fatigue that impact HRQOL. These 2 symptoms vary in timing, intensity, quality, and degree of discomfort and cause a reduction in performance. By identifying which physiological, psychological, and situational factors cause a decrease in HRQOL, interventions can be implemented to reduce or ameliorate the symptom experience resulting in an improvement in HRQOL. The purposes of this research study were to (a) identify relationships among the psychological factors (depression, anxiety, stress), physiological factor (6-Minute Walk Test [6MWT]), situational factor (social support), and HRQOL and (b) test a structural equation model in which psychological factors (depression, anxiety, stress), physiological factor (6MWT), and situational factor (social support) predict HRQOL in adults with PH.
METHODS Design and Sample
A cross-sectional, predictive, correlational design was used to test relationships among depression, anxiety, stress, social support, 6MWT, and HRQOL in adults with PH. Potential participants who met eligibility criteria were recruited. Eligibility criteria included English-speaking participants between the ages of 21 and 80 years, a medical diagnosis based on a mean pulmonary arterial pressure greater than 25 mm Hg measured via right-sided heart catheterization, and meeting the World Health Organization Clinical Classification (WHO-CC) of PH. The WHO-CC includes pulmonary arterial hypertension (class 1), PH owing to left-sided heart disease (class 2), PH owing to lung disease and hypoxia (class 3), chronic thromboembolic PH (class 4), and PH with unclear multifactorial mechanisms (class 5).
Minimum sample size in structural equation modeling should be no less than 200 or 10 times the number of parameters to be estimated. 10 With 5 measured factors, depression, anxiety, stress, 6MWT, and social support, the number of parameters to be estimated was 15. The minimum sample required for the present study was 150. The study setting consisted of the Research Room at the PH Association's 10th International PH Conference and Scientific Sessions in Orlando, Florida, and a PH clinic in southeast Louisiana. The Research Room at the PH Association's 10th International Conference is dedicated to assisting researchers further their studies by allowing for the collection of data from patients with PH. Approximately 230 patients with PH participated in the Research Room. Data collection occurred over a 1-year period.
Instruments
Two instruments were used to collect data for study variables. The 21-item Depression Anxiety Stress Scale (DASS-21) was used to assess for depression, anxiety, and stress, and the Dartmouth Cooperative Functional Assessment (COOP) charts were used to assess for social support and HRQOL.
The DASS-21 assesses the severity of core symptoms of depression, anxiety, and stress in individuals older than 17 years. The DASS-21 is internally consistent and a valid measure of these negative affective states. The Cronbach's ! internal consistency coefficients were .81 for depression score, .92 for anxiety score, and .88 for the stress score. The DASS-21 has good convergent validity and acceptable discriminative validity as several studies have reported convergent and discriminant correlations between the DASS-21 subscales and Beck Depression Inventory, Beck Anxiety Inventory, and Hospital Anxiety and Depression Scale. 11 The COOP charts provide a rapid way to assess the health and functioning of subjects in primary care practices. The COOP charts are a simple tool that is reliable as test-retest reliability with the same method of administration was conducted in several settings. In 1-hour test-retest studies, the correlation coefficients ranged from 0.93 to 0.99 and .'s ranged from 0.80 to 0.97. The COOP charts are also valid as convergent validity correlations were 0.71 with the Short-Form 20. 12 Exercise tolerance was measured by the 6MWT which is the distance in meters walked by the subject over a 6-minute period. The American Thoracic Society 13 recommends the 6MWT for measuring the response to medical interventions in patients with moderate to severe heart or lung disease. The 6MWT has been used as a 1-time measure of functional status of patients, as well as a predictor of morbidity and mortality. Literature has demonstrated a relationship between walk distance and 3-year survival. Only 20% of patients with PH survived more than 3 years if walk distance was less than 332 m. 13, 14 Procedure After institutional review board approval was obtained, potential subjects who met inclusion criteria were identified, and voluntary consent obtained. Data were collected via retrospective medical record review, patient review, and concurrent administration of DASS-21 and the COOP charts. The physiological factor collected via retrospective medical review or patient review included the 6MWT. The psychological factors (depression, anxiety, and stress), situational factor (social support), and HRQOL were collected concurrently via the DASS-21 and COOP charts.
Data Analysis
The data collected were analyzed using the Statistical Analysis System 9.2 (SAS Institute Inc, Cary, North Carolina). Descriptive statistics were used for demographic characteristics and measured variables. Pearson correlation coefficients were used to identify relationships among the measured variables. Structural equation modeling with path analysis was used to examine the fit between the proposed model and data collected. The model fit was tested with 3 fit indices: absolute, incremental, and parsimonious. The absolute indices were # 2 (P 9 .05), # 2 /df (desired value, G3), and goodness-of-fit index (desired value, Q0.90). The incremental fit was determined with the Normed Fit Index (90.095). The parsimony of the proposed model was tested using adjusted goodness of fit (90.90).
RESULTS

Descriptive Statistics
A total of 166 adult PH patients, which included WHO-CC 1 (92.8%), WHO-CC 2 (3.6%), WHO-CC 3 (1.8%), WHO-CC 4 (0.6%), and WHO-CC 5 (1.2%), participated in this study. The mean age of the participants was 52 (SD, 13.7) years. Most subjects were female (87.3%) and white (79.5%; Table 1) .
Depression, anxiety, stress, reduction in social support, decreased walk distance, and diminished HRQOL were present in the adult PH population. Depression was prevalent in 33% (n = 54) of the sample. The prevalence of anxiety in the sample was 62% (n = 103). Forty percent (n = 66) of the sample reported stress. Thirty percent (n = 49) of the sample reported a reduction in social support. Thirty-nine percent (n = 64) walked less than 301 m for the 6MWT. Forty-five percent (n = 74) of the sample reported a reduction in HRQOL.
Correlational analysis (Table 2 ) supported the relationships among the study variables in the proposed predictive model for adults with PH HRQOL (Figure 1) . Depression, anxiety, and stress were inversely correlated with HRQOL (P G .01). Reduction in social support and decreased distance walked in 6 minutes were negatively correlated with HRQOL (P G .01).
Testing the Proposed Model
The proposed predictive model for adults with PH HRQOL was established based on literature review and previous pilot study. The researcher conducted a pilot study that established relationships between depression, anxiety, stress, social support, and HRQOL. The data fit the proposed predictive model for adults with PH HRQOL within an acceptable range as indicated by the criteria: # 2 = 14.3315, # 2 /df = 2.86, goodness-of-fit index = 0.9898, Normed Fit Index = 0.9547, and adjusted goodness of fit = 0.9541. Based on the statistical analyses, the data collected from the adult PH population fit the proposed predictive model for adults with PH HRQOL.
Standardized path coefficients are the effect sizes calculated by the model estimation program and denote the strength of the relationships among the variables. Figure 2 presents the standardized path coefficients of social support, stress, anxiety, depression, 6MWT, and HRQOL.
Based on the statistical analyses, the researcher was unable to determine which psychological, physiological, or situational factor was the best predictor of HRQOL in the adult PH population. Because of the covariances among the variables of depression, anxiety, stress, social support, and 6MWT, it was not possible to predict which variable best predicted HRQOL in the adult PH population. This may be attributed to the lack of defining characteristics among the concepts of depression, anxiety, and stress. The concepts of depression, anxiety, and stress may be related so close conceptually that it is difficult to separate one concept from another in the adult PH population.
DISCUSSION
Despite not being able to identify the best predictor of HRQOL in the adult PH population, several findings are particularly noteworthy in the predictive model for adults with PH HRQOL. The statistical analyses indicated an increase in depression was correlated with a reduction in HRQOL in the adult PH population. Depression occurs quite often in patients with chronic breathing disorders as 80% of patients with a chronic breathing disorder experienced clinically significant levels of depression. 15 Of the depressed patients, only 31% were receiving treatment. Specifically, REVEAL PH Disease Management discovered 25% of patients with PH experience depression. 6 Depression undiagnosed or untreated may lead to a diminished HRQOL as the frequency of the symptoms of 16 reported depressive disorder was associated with significant impairments in HRQOL. Individuals who were depressed had comparable or worse physical, psychosocial, and role functioning and increased functional disability than did individuals with chronic disease without depression. The longer a patient remains depressed, the less chance of a complete recovery, thereby leading to a greater dysfunction. 16 The concept anxiety also impacts HRQOL negatively in the patient with PH. Patients in the research study who reported anxiety also reported a reduction in HRQOL. Anxiety is a common comorbidity in patients with PH, but its identification and management are often inadequate. Past research reported 10.4% of patients with PH experienced anxiety and anxiety increases as the severity of the disease progresses. 8 Individuals who experienced anxiety believed the anxiety had a significant impact on HRQOL. Many patients with a chronic lung disease were fearful of becoming short of breath, believing the shortness of breath was a precursor to an anxiety attack. Because of this fear, many avoided physical exertion, and this had a negative impact on HRQOL. Patients with an anxiety disorder had impairment in role functioning and social life. Anxiety had an effect on friends and family of patients with a chronic lung disease because of the patient's irritable and difficult behavior. Patients reported a low overall life satisfaction. 17 Stress is a concept in the predictive model that also had a negative impact on HRQOL in the PH population. Patients with PH in the research study who reported an increase in stress also reported a reduction in HRQOL. Stress occurs as a result of the brain's response to any demand. Change, whether mild or major, can trigger this response. Patients living with PH may experience stress due to the seriousness and unfamiliarity of the disease. 2 Chronic stress in the patient with PH can significantly exacerbate PH symptoms of dyspnea and fatigue. Chronic stress causes adrenalin to be released in the patient with PH, which damages the arterial linings and causes an increase in right ventricular afterload. 2 Mental stress can increase right ventricular afterload in the patient with PH as a result of an increase in mean pulmonary arterial pressure, pulmonary arterial systolic pressure, pulmonary arterial diastolic pressure, and pulmonary vascular resistance with a resultant decrease in stroke volume. The increase in right ventricular afterload and decrease in stroke volume result in a ventilation/perfusion mismatch, which may exacerbate the symptoms of dyspnea and fatigue. 18 The data revealed a reduction in 6MWT distance was associated with a decrease in HRQOL in the adult PH population. The literature supports this finding as 6MWT distance less than 332 m was associated with increased mortality. 19 The purpose of the 6MWT is to test exercise tolerance in patients with chronic lung and heart disease. The strongest indication for the 6MWT is for measuring the response to medical interventions in patients with moderate to severe heart or lung disease. The 6MWT may also be used as a 1-time measure of functional status of patients, as well as a predictor of morbidity and mortality. 12 Statistical analyses also revealed a reduction in social support was associated with a reduction in HRQOL in the adult PH population. Social support consists of friends, family, and peers and is different from a support group, which is a structured meeting run by a healthcare professional. A strong social support is able to assist the patient with PH through stress and difficult times. 2 Statistical analyses revealed the data collected from the adult PH population fit the predictive model for adults with PH HRQOL. Adults with PH may experience an increase in depression, anxiety, stress, reduction in social support, decreased physical tolerance, and reduction in HRQOL.
Study Limitations
A limitation within this study includes a convenience sample of white patients. The participants attending the PH Association's 10th International PH and Scientific Sessions in Orlando, Florida, may be highly motivated and more compliant than the sample from the PH clinic in southeast Louisiana. In addition, the data were gathered at 1 setting representing a cross-sectional rather than a longitudinal view of the population. Another limitation was a temporal gap between the psychological, physiological, and situational factors. The psychological factors (depression, anxiety, and stress) and situational factor (social support) were collected concurrently, and the physiological factor (6MWT) was collected retrospectively. This limits inferences related to the direct impact of the psychological, physiological, and situational factors on HRQOL.
Implications for the Clinical Nurse Specialist
The clinical nurse specialist (CNS) plays an important role in identifying the concepts of depression, anxiety, and stress in the patient with PH. This assessment is integral in order to appropriately distinguish what knowledge, skills, or resources the patient with PH will need. A referral to a mental health CNS for the patient with PH who is depressed may be warranted for further evaluation and placement on antidepressant therapy. Counseling for the patient with newly diagnosed PH and his/her caregiver either together or separately is important as voicing worries and concerns may be therapeutic. Clinical nurse specialists can also assist the patient with PH in establishing a support system by encouraging the patient with PH to volunteer, join a gym, go back to school, or search the Internet. 2 Screening for anxiety should focus on nonsomatic elements of anxiety, such as fear, rather than somatic symptoms such as breathlessness. Treatment options for the anxious patient with PH include psychotherapy, benzodiazepines, selective serotonin reuptake inhibitors, and pulmonary rehabilitation. Pulmonary rehabilitation involves repeatedly exposing the patient with PH to breathing discomfort under safe, monitored conditions. Patients with PH benefit by the desensitization of fear associated with sensations of dyspnea.
The concept of stress once identified needs to be eliminated because of its detrimental effects on pulmonary hemodynamics. Stress can further increase pulmonary artery pressures causing an increase in dyspnea and fatigue. Treatment options include meditation, yoga, prayer, progressive muscle relaxation, hypnosis, guided imagery, support groups, and referral to a qualified mental healthcare provider especially if suicidal thoughts are present and if alcohol or substance abuse is occurring.
A patient with PH with a diminished 6MWT distance and decreased functional ability should work with a multidisciplinary team consisting of nursing, medicine, and allied health to establish target values and treatment goals. Target values and treatment goals should be individualized. Low-grade resistance training should be implemented initially for patients who have not participated in much exercise prior to diagnosis. Cardiopulmonary rehabilitation program is an option for patients with PH who are fearful of exercise at home and prefer exercise in a controlled setting.
Pulmonary hypertension is a devastating condition that affects predominately women. A HRQOL assessment should be performed throughout the clinical course. Understanding HRQOL and factors affecting HRQOL is important in the care and management of patients with PH. Health-related quality of life assessments provide a unique assessment of the patient's satisfaction with the psychological, physiological, and situational domains of life.
Pulmonary hypertension is a progressive disease with no cure; however, the management of PH continues to evolve. There has been an increase in the number of medications in the last several years that lower mean pulmonary artery pressure and pulmonary vascular resistance and improve cardiac output with little positive impact on HRQOL. The CNS must take into consideration psychological, physiological, and situational factors that affect HRQOL. By understanding the complexity of PH; assessing for the concepts of depression, anxiety, stress, and social support; and evaluating 6MWT distance, the CNS will be able to identify these concepts in their early stages and provide the best possible interventions to improve patient outlook and HRQOL.
